Immunome
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $4,015 | $2,926 | $2,738 | $2,910 |
Gross Profit | 4,015 | 2,926 | 2,738 | 2,910 |
EBITDA | -45,758 | -43,910 | -55,003 | -43,245 |
EBIT | -46,478 | -44,636 | -55,598 | -43,816 |
Net Income | -43,397 | -41,640 | -80,249 | -47,100 |
Net Change In Cash | 4,015 | 2,926 | 2,738 | 2,910 |
Free Cash Flow | -50,306 | -56,720 | -43,435 | -35,706 |
Cash | 143,876 | 257,613 | 143,351 | 155,568 |
Basic Shares | 87,010 | 79,410 | 62,703 | 60,205 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $9,041 | $14,018 | $6,627 | $0 |
Gross Profit | 9,041 | 14,018 | -631 | -755 |
EBITDA | -151,354 | -28,000 | -36,265 | -23,946 |
EBIT | -153,456 | -28,728 | -36,896 | -24,701 |
Net Income | -292,963 | -106,806 | -37,513 | -24,711 |
Net Change In Cash | 9,041 | 14,018 | 6,627 | 0 |
Cost of Revenue | -28,906 | |||
Free Cash Flow | -117,967 | -8,399 | -28,938 | -18,305 |
Cash | 143,351 | 98,679 | 20,323 | 49,229 |
Basic Shares | 58,639 | 19,843 | 12,126 | 11,538 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.50 |
2025-03-31 | -$0.52 |
2024-12-31 | -$1.11 |
